UNSPSC 51191960: Thiamine triphosphate

This classification denotes a b vitamin with the molecular formula C12H19N4O10P3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 464M6AQ7IV, chemically known as thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl)-, inner salt, p,p',p''-trioxide, but more generally known as thiamine triphosphate, which bears US NIH Compound Identifier 511.

European Medicines Agency schedules thiamine triphosphate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10969MIG. Most nations, for tariff purposes, schedule thiamine triphosphate under HS 29362200. SMILES: CC1C(SC[N+]1CC2CNC(NC2N)C)CCOP(=O)([O-])OP(=O)(O)OP(=O)(O)O.

UNSPSC 51191960 Thiamine triphosphate is a Commodity code that captures specialized chemical and pharmaceutical products state and local governments procure for public health, water treatment, and medical supply operations. Recent opportunities under this code show state and local buyers sourcing both industrial chemicals for municipal infrastructure and generic pharmaceuticals for distributed public health facilities. The City of Meriden's bid for sodium bisulfite illustrates the industrial-chemical end — chemical commodities used in water pollution control operations where unit pricing and delivery schedules drive the procurement. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic pharmaceuticals and OTC products illustrates the pharmaceutical end — multi-state cooperative purchasing vehicles that aggregate demand across state agencies and local government health systems, with manufacturers supplying through authorized wholesalers and contracting on fixed or net-price terms. Issuing bodies include municipal utilities, state departments of administration, and multi-state cooperative purchasing consortia. Both opportunities impose compliance requirements — Connecticut insurance and bonding standards for the municipal chemical buy, and FDA cGMP and Drug Supply Chain Security Act certification for the pharmaceutical cooperative.

Geographic activity spans the Upper Midwest and Northeast, with MMCAP representing Minnesota state procurement and participating local governments across Oregon and other coalition members, and the City of Meriden representing Connecticut municipal procurement. The City of Meriden IFB for sodium bisulfite closed July 29, 2026, requiring General Liability coverage of $1,000,000 to $2,000,000 and performance and payment bonds. The MMCAP RFP (due March 26, 2026) sought multiple awards for generic pharmaceuticals and OTC products, with pricing weighted at 75 percent of the evaluation, administrative compliance at 15 percent, and EDI capability and fee acceptance at 10 percent combined; awarded vendors were to be operational July 1, 2026, with a two-year initial term and optional extensions through June 30, 2028. Price competitiveness and ability to support chargeback relationships with AmerisourceBergen (Cencora), Cardinal Health, and Morris & Dickson drive selection under the pharmaceutical track.